Akero Therapeutics Stock Forecast - Accumulation Distribution
| AKRO Stock | USD 32.73 1.53 4.90% |
Akero Stock Forecast is based on your current time horizon. Although Akero Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Akero Therapeutics' systematic risk associated with finding meaningful patterns of Akero Therapeutics fundamentals over time.
Akero |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 16914.28 | 64738.59 |
| Check Akero Therapeutics Volatility | Backtest Akero Therapeutics | Trend Details |
Akero Therapeutics Trading Date Momentum
| On October 30 2024 Akero Therapeutics was traded for 30.70 at the closing time. The top price for the day was 32.70 and the lowest listed price was 30.69 . The trading volume for the day was 641.1 K. The trading history from October 30, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.25% . The overall trading delta against the current closing price is 1.48% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Akero Therapeutics to competition |
Other Forecasting Options for Akero Therapeutics
For every potential investor in Akero, whether a beginner or expert, Akero Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Akero Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Akero. Basic forecasting techniques help filter out the noise by identifying Akero Therapeutics' price trends.Akero Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Akero Therapeutics stock to make a market-neutral strategy. Peer analysis of Akero Therapeutics could also be used in its relative valuation, which is a method of valuing Akero Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Akero Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Akero Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Akero Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Akero Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Akero Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Akero Therapeutics shares will generate the highest return on investment. By undertsting and applying Akero Therapeutics stock market strength indicators, traders can identify Akero Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 47554.43 | |||
| Daily Balance Of Power | 0.8053 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 32.0 | |||
| Day Typical Price | 32.24 | |||
| Price Action Indicator | 1.49 | |||
| Period Momentum Indicator | 1.53 |
Akero Therapeutics Risk Indicators
The analysis of Akero Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Akero Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting akero stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.34 | |||
| Semi Deviation | 2.68 | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.44 | |||
| Downside Variance | 8.84 | |||
| Semi Variance | 7.19 | |||
| Expected Short fall | (2.44) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Akero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Akero Stock
| 0.79 | MTEM | Molecular Templates | PairCorr |
| 0.78 | NKTX | Nkarta Inc | PairCorr |
| 0.76 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.69 | TPST | Tempest Therapeutics | PairCorr |
| 0.68 | VALN | Valneva SE ADR | PairCorr |
The ability to find closely correlated positions to Akero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akero Therapeutics to buy it.
The correlation of Akero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Akero Therapeutics to cross-verify your projections. To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akero Therapeutics. If investors know Akero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.78) | Return On Assets (0.23) | Return On Equity (0.36) |
The market value of Akero Therapeutics is measured differently than its book value, which is the value of Akero that is recorded on the company's balance sheet. Investors also form their own opinion of Akero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akero Therapeutics' market value can be influenced by many factors that don't directly affect Akero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.